Brimonidine Tartrate

4, 8 mg Film Coated Tablet

50, 150 mg Film Coated Tablet

0.01% Ophthalmic Eye Drops

0.03 %, 3 ml Ophthalmic Eye Drops (LDPE bottle with dropper)

3 ml LDPE, transparent plastic bottle Eye Drops

3.5 mg Powder for Solution for IV/SC Injection

200 µg, 400 µg Capsule for Inhalation

0.25 mg/ml (2 ml) 0.50 mg/ml (2 ml) Vial Containing Inhalation Susp. for Nebulisation, Single Dose

0,5 mg/2 ml 1 mg/2 ml Solution for Nebulization (single-dose vials)

320 µg/9 µg (60 dose) Aerosol (MDI) 160 µg/4.5 µg (60 & 120 dose) Aerosol (MDI) 80 µg/4.5 µg (120 dose) Aerosol (MDI)

400 µg/12 µg Capsule for Inhalation 200 µg/12 µg Capsule for Inhalation 200 µg/6 µg Capsule for Inhalation

5 mg Capsule

Deva EU Markets Product List

Our product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.

Currently, its product portfolio contains more than 650 products in 14 therapeutic areas, ranging from oncology to cardiology, respiratory system and ophthalmology, as well as medical devices.